SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-21-016068
Filing Date
2021-05-06
Accepted
2021-05-06 06:11:48
Documents
13
Period of Report
2021-04-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A nt10023917x7_8ka.htm   iXBRL 8-K/A 34289
2 EXHIBIT 99.4 nt10023917x7_ex99-4.htm EX-99.4 1182214
  Complete submission text file 0001140361-21-016068.txt   1411672

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210430.xsd EX-101.SCH 3917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210430_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210430_pre.xml EX-101.PRE 16038
6 EXTRACTED XBRL INSTANCE DOCUMENT nt10023917x7_8ka_htm.xml XML 4063
Mailing Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2
Business Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 2064329325
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38594 | Film No.: 21895589
SIC: 2833 Medicinal Chemicals & Botanical Products